News - Asia-Pacific

Filter

Current filters:

Asia-Pacific

Popular Filters

51 to 75 of 956 results

Sanofi Pasteur inks deal with Korea’s SK Chemical on vaccines

Sanofi Pasteur inks deal with Korea’s SK Chemical on vaccines

19-03-2014

In a second collaboration in less than a month, Sanofi Pasteur, the vaccines division of French drug…

Asia-PacificLicensingPharmaceuticalResearchSanofiSanofi PasteurSK ChemicalVaccines

Asia-Pacific NSCLC market to reach $2.9 billion by 2019

Asia-Pacific NSCLC market to reach $2.9 billion by 2019

18-03-2014

The non-small cell lung cancer (NSCLC) therapeutics market value in the Asia-Pacific (APAC) region -…

Asia-PacificAustraliaChinaIndiaJapanMarkets & MarketingOncologyPharmaceutical

Australian regulator finds no definite melanoma link for natalizumab

Australian regulator finds no definite melanoma link for natalizumab

18-03-2014

Australia’s Therapeutic Goods Administration revealed today that it is monitoring reports of melanoma…

Asia-PacificAustraliaBiogen IdecBiotechnologyNatalizumabNeurologicalRegulationTysabri

Sun Pharma latest Indian generic drugmaker to fall foul of US FDA

Sun Pharma latest Indian generic drugmaker to fall foul of US FDA

14-03-2014

Even as India-based drug majors Ranbaxy and Wockhardt reel under the impact of US Food and Drug Administration…

Asia-PacificGenericsIndiaProductionRegulation

Taiwan’s TaiGen Biotech receives domestic marketing approval for Taigexyn

13-03-2014

Taiwan-based drug developer TaiGen Biotechnology says that the Taiwan Food and Drug Administration has…

Antibiotics and Infectious diseasesAsia-PacificBiotechnologyRegulationTaiGen BiotechTaigexyn

GMiA calls on Australian government to think before irreversible damage occurs to the generic medicines industry

GMiA calls on Australian government to think before irreversible damage occurs to the generic medicines industry

13-03-2014

At the Annual Professional Pharmacy (APP) conference in Australia today, Mark Crotty, chairman of the…

Asia-PacificAustraliaGenericsHealthcarePolitics

Japan’s market for schizophrenia treatment to double by 2022

Japan’s market for schizophrenia treatment to double by 2022

12-03-2014

Japan’s schizophrenia treatment market value will undergo significant growth over the coming decade,…

Asia-PacificJapanMarkets & MarketingNeurologicalPharmaceutical

Mylan pushes further into India, introducing critical care segment

Mylan pushes further into India, introducing critical care segment

12-03-2014

US generics major Mylan says its Indian subsidiary has launched a Critical Care segment in India. The…

AmbisomeAntibiotics and Infectious diseasesAsia-PacificGenericsIndiaMarkets & MarketingMylan Laboratories

China Summit paves the way for Australian companies, says AusBiotech

China Summit paves the way for Australian companies, says AusBiotech

11-03-2014

Recognizing the leading role China will take globally in the future of life sciences, trade group AusBiotech…

Asia-PacificAustraliaBiotechnologyChinaManagementResearch

Daiichi Sankyo unit will not hit H5N1 vaccine supply deadline

Daiichi Sankyo unit will not hit H5N1 vaccine supply deadline

10-03-2014

Japanese drug major Daiichi Sankyo has updated on the H5N1 influenza vaccine project, revealing that…

Asia-PacificDaiichi SankyoJapanPharmaceuticalProductionVaccines

GSK increases stake in Indian Pharma subsidiary to 75%

GSK increases stake in Indian Pharma subsidiary to 75%

10-03-2014

UK pharma giant GlaxoSmithKline says that, following the voluntary open offer undertaken by its Indian…

Asia-PacificGlaxoSmithKlineIndiaMergers & AcquisitionsPharmaceutical

Takeda files for diabetes drug trelagliptin succinate approval in Japan

Takeda files for diabetes drug trelagliptin succinate approval in Japan

09-03-2014

Takeda Pharmaceutical, Japan’s largest drugmaker, has submitted a New Drug Application to the Japanese…

Asia-PacificBlopressCardio-vascularDiabetesJapanPharmaceuticalRegulationResearchTakeda Pharmaceuticalstrelagliptin

AstraZeneca to establish cancer research program with Korea’s HIDI

AstraZeneca to establish cancer research program with Korea’s HIDI

07-03-2014

Anglo-Swedish pharma major AstraZeneca has signed a memorandum of understanding (MoU) with the South…

Asia-PacificAstraZenecaOncologyPharmaceuticalResearch

Streamlined PBS pricing processes to improve access to medicines in Australia

Streamlined PBS pricing processes to improve access to medicines in Australia

07-03-2014

From April 1, the Australian government will implement a new streamlined process to reduce the time taken…

Asia-PacificAustraliaPharmaceuticalPricingRegulation

Asia-Pacific region sees boom in Biotech investment

Asia-Pacific region sees boom in Biotech investment

07-03-2014

The Asia-Pacific (APAC) region is experiencing a significant boom in the volume of private equity (PE)…

Asia-PacificBiotechnologyFinancialPatents

Tacrolimus Sandoz gets sole subsidy supply status in New Zealand

Tacrolimus Sandoz gets sole subsidy supply status in New Zealand

07-03-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC has decided to award immunosuppressant drug…

Asia-PacificGenericsImmunologicalsMarkets & MarketingNew ZealandNovartisPricingSandozTacrolimus Sandoz

Lilly and Novast to expand manufacturing facility in Nantong, China

Lilly and Novast to expand manufacturing facility in Nantong, China

06-03-2014

US pharma major Eli Lilly and China-based generic and specialty pharmaceutical company Novast Laboratories…

Asia-PacificChinaEli LillyNovast LaboratoriesPharmaceuticalProduction

Biostar Pharma partners with Shaanxi University to co-develop liver cancer drug

06-03-2014

China-based pharma and health supplements firm Biostar Pharmaceuticals (Nasdaq: BSPM) has signed a letter…

Asia-PacificBiostar PharmaChinaOncologyPharmaceutical

AusBiotech continues its call for further tax reform in Australia

AusBiotech continues its call for further tax reform in Australia

04-03-2014

Building on the strategic plan that was presented at AusBiotech national conference last November by…

Asia-PacificAustraliaBiotechnologyFinancialResearch

India now making moves into pharma innovation

India now making moves into pharma innovation

03-03-2014

In what must be seen as a significant change in focus, India is now seeing a surge of innovative research…

Asia-PacificBiosimilarsIndiaMarkets & MarketingPharmaceuticalResearch

Natco prevails in Indian Copaxone patent dispute with Teva

Natco prevails in Indian Copaxone patent dispute with Teva

03-03-2014

Hyderabad, India-based Natco Pharma has won a significant patent battle against Israeli generics giant…

Asia-PacificCopaxoneGenericsIndiaNatco PharmaPatents & Trade marksTeva Pharmaceutical Industries

Fresenius Kabi to invest A$47 million in Australian production plant

01-03-2014

Germany-based Fresenius Kabi is establishing a A$47 million ($42 million) state-of-the-art pharmaceutical…

Asia-PacificAustraliaFresenius KabiPharmaceuticalProduction

Asia-Pacific epilepsy therapeutics market continues to grow as new drugs emerge

28-02-2014

The epilepsy therapeutics market value in the Asia-Pacific region - Australia, China, India and Japan…

Asia-PacificEisaiFycompaGlaxoSmithKlineKeppraMarkets & MarketingNeurologicalPharmaceuticalTrobaltUCBVimpatZonegran

Australian patients benefit from PBS changes; cancer research

27-02-2014

New medicines for glaucoma, diabetes and advanced soft tissue sarcoma have been approved for listing…

Asia-PacificAustraliaDiabetesFinancialHealthcareKombiglyzeOncologyPharmaceuticalResearchTrajentaVotrient

51 to 75 of 956 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top